Pest controlMold & moistureHome maintenanceSmart homeAbout us
Having antibodies to mold on a test isn't the same as having symptoms from mold

How Many People in the US Are Allergic to Mold? What the Data Show

No single count exists. US surveys find about 1 in 10 people have mold antibodies, but fewer get symptoms. What the numbers mean and what to do.

10 min read

No one has an exact count of Americans with mold allergy. The best national data show that about 1 in 10 people have allergy antibodies to common molds. In the National Health and Nutrition Examination Survey (NHANES) 2005–2006, 10.4% of people aged 6 and older tested positive for Alternaria or Aspergillus. In the earlier NHANES III survey (1988–1994), 12.9% of people aged 6 to 59 had a positive skin test to Alternaria. But a positive test shows sensitization, not necessarily allergy symptoms. Medical groups have estimated that only about half of sensitized people, or roughly 5% of the population, will have mold allergy symptoms at some point. Those estimates are decades old, so treat every figure as a range rather than a precise count.

The earlier version of this article said "3–10%" of Americans are allergic to mold, which works out to 10 to 33 million people. That range appears in review articles, but we couldn't trace it to a US population study. The old version also placed the 12.9% skin test result in the wrong survey and misdescribed the debate over a widely quoted 10% figure. Those points are corrected below.

The Best US Numbers, and What Each One Measures

National estimates come from a few types of studies. Each measures something slightly different.

  • NHANES III, 1988–1994 (skin tests). This federal survey gave allergy skin prick tests to a nationally representative sample. Arbes and colleagues (2005) found that 54.3% of participants reacted to at least one of 10 common allergens. A 2015 review of mold allergens reports that about 12.9% of the population aged 6 to 59 reacted to Alternaria alternata, a common outdoor mold.
  • NHANES 2005–2006 (blood tests). Instead of skin tests, this survey measured allergen-specific IgE antibodies in blood. Salo and colleagues (2014) found that 44.6% of people aged 6 and older were sensitized to at least one allergen. For molds, 10.4% were sensitized to Alternaria, Aspergillus, or both. That makes molds less common than plant allergens (27.1%), dust mites (20.3%), or pets (15.7%).
  • Clinical lab data, 2014–2019. A 2023 study in the *Journal of Allergy and Clinical Immunology* analyzed nearly 7.9 million blood test results for 17 fungi from about 1.65 million US patients. Twenty-two percent tested positive to at least one fungal allergen. Candida albicans was the most common at 18.6%, followed by Alternaria at 16.6%. These were patients whose clinicians ordered allergy blood tests, not a random sample. The study also counted a lower antibody level as positive than NHANES 2005–2006 did. So its rates describe people being evaluated for allergies, not the general public.

These studies can't simply be lined up and compared. The NHANES 2005–2006 authors note that skin and blood tests perform differently, which makes it hard to compare results with the earlier surveys. The surveys also tested only one or two molds, while people can be sensitized to many others.

Sensitized vs. Actually Allergic

This distinction explains most of the confusion around mold allergy statistics.

Sensitization means your immune system has made IgE antibodies to a mold, which shows up on a skin or blood test. Clinical allergy means you actually get symptoms, such as sneezing, congestion, itchy eyes, or asthma flares, when you're exposed. The NHANES 2005–2006 researchers write that allergen-specific IgE "does not necessarily correspond to clinical allergy (i.e., symptoms)." They add that the likelihood of real allergy does rise with test results.

Two professional statements converted sensitization into a rough symptom estimate:

  • The American College of Occupational and Environmental Medicine's (ACOEM) 2003 evidence-based statement on molds estimated that about 10% of the population has allergic antibodies to common inhalant molds. It said about half of them, roughly 5% of the population, would be expected to have allergic symptoms from molds at some time.
  • The American Academy of Allergy, Asthma & Immunology's (AAAAI) 2006 position paper on the medical effects of mold exposure gave the same estimates: about 10% with IgE antibodies to common inhalant molds, and about 5% predicted to have symptoms at some time. The AAAAI notes its position statements are for reference only after five years.

So "10% of Americans are allergic to mold" is a misreading. The 10% figure described antibodies. The symptom estimate was about half that. Both statements also said outdoor molds generally matter more for sensitization and disease than indoor molds.

Why the Often-Quoted 10% Figure Is Debated

The ACOEM statement is controversial, but not mainly because of its prevalence estimate. In 2008, physician James Craner published a critique in the *International Journal of Occupational and Environmental Health*. He argued that the statement's authors had undisclosed conflicts of interest and that it read like a litigation defense report. His concern was mainly how the statement handled evidence linking damp, moldy buildings to health problems, and how defendants later used it in mold lawsuits.

That debate is a good reason to read the ACOEM statement critically. It doesn't prove the 10% sensitization estimate was wrong. The later NHANES 2005–2006 blood test result of 10.4% is broadly consistent with it, though the surveys used different methods and tested only a few molds.

Why No One Can Give a Single Precise Number

  • Different tests give different answers. Skin prick tests and blood IgE tests don't perform identically, and positive cutoffs vary. The 2023 lab study counted a lower antibody level as positive than NHANES 2005–2006 did.
  • Only a few molds get tested. Population surveys checked Alternaria and Aspergillus. The lab study tested 17 fungi and found more positives.
  • Who gets tested matters. A representative national survey will show lower rates than a group of patients sent for allergy testing.
  • The national data are old. The nationally representative surveys cited here collected their data in 1988–1994 and 2005–2006.
  • Place and personal factors vary. The 2023 lab study found higher fungal sensitization in males, teens aged 10 to 19, and people with asthma or atopic dermatitis. Rates were also higher in urban areas and grassland regions than in forested areas.

For those reasons, we don't convert these percentages into a headcount of "allergic Americans." A single number would suggest more precision than the evidence supports.

Who Is More Likely To Have a Problem With Mold

Mold sensitization matters most for people with allergic disease. The AAAAI position paper notes that people with allergic asthma, allergic rhinitis, and atopic dermatitis commonly have antibodies to molds along with other allergens. It also says sensitization to Alternaria has been linked to the presence, persistence, and severity of asthma.

The CDC says people with asthma or mold allergy may have severe reactions to mold. People with weakened immune systems or chronic lung disease can get lung infections from mold. For a broader look at which health effects are well established and which are disputed, see what mold illness is.

Signs You May Have a Mold Allergy

According to the American College of Allergy, Asthma and Immunology (ACAAI), symptoms can include:

  • Nasal congestion, runny nose, and sneezing
  • Irritated eyes
  • Coughing, wheezing, or an itchy throat
  • Asthma symptoms that get worse

The AAAAI's mold allergy overview says many people notice symptoms outdoors on days with high mold spore counts. Symptoms can also happen indoors if mold is growing in a home, school, or workplace. Patterns can be a clue: symptoms that flare in damp, musty places, during certain seasons, or on high-count days. See what counts as a high mold count and what time of year mold is worst for help reading those patterns.

Getting Tested and Treated

Don't rely on a home test to diagnose a mold allergy. An allergist can use skin prick or blood tests to help pinpoint the allergy, and can weigh the results against when and where your symptoms happen. That matters because, as the NHANES researchers note, a positive test alone doesn't necessarily mean you'll have symptoms.

Treatment options described by the ACAAI and AAAAI include:

  • Symptom medications. Antihistamines, decongestants, eye drops, and nasal sprays.
  • Allergy shots. The AAAAI describes immunotherapy as a treatment that can provide long-term relief. Ask an allergist whether it's appropriate for your specific mold sensitivity.

Get prompt medical care for wheezing, chest tightness, or trouble breathing, especially if you have asthma.

Reducing Mold Exposure at Home

You can't avoid outdoor mold spores completely, but you can keep mold from growing indoors:

  • Fix leaks and dry wet areas quickly. The EPA says mold will most likely come back if you clean it up but don't fix the water problem.
  • Control humidity. The EPA recommends keeping indoor relative humidity below 60%, ideally between 30% and 50%. Use exhaust fans, a dehumidifier, or an open window, as the ACAAI suggests. Our guide to indoor humidity for mold prevention explains how to measure and adjust it.
  • Keep up with the damp spots. The ACAAI recommends regularly cleaning garbage cans and refrigerator drip pans, clearing gutters, and making sure drainage flows away from your foundation.
  • Limit outdoor exposure on high-count days. The AAAAI suggests staying inside when mold counts are high, avoiding uncut fields, and showering after time outdoors.
  • Size up visible mold. The EPA says most people can clean up an area smaller than about 10 square feet themselves. It also advises anyone with health concerns, such as allergies or asthma, to consult a health professional before starting cleanup. For larger areas, hidden mold, or a musty smell you can't find, see who to call for a mold inspection.

Frequently Asked Questions

What percentage of Americans are allergic to mold?

There's no exact figure. National surveys found that about 10% to 13% of Americans tested had antibodies to common molds. Professional estimates from the early 2000s suggest roughly half of sensitized people, about 5% of the population, will have mold allergy symptoms at some point.

Is mold allergy more common than pollen or dust mite allergy?

Not in the national data. In NHANES 2005–2006, sensitization to molds (10.4%) was less common than sensitization to plant allergens (27.1%), dust mites (20.3%), or pets (15.7%).

Does a positive mold allergy test mean I'm allergic?

Not necessarily. A positive skin or blood test shows sensitization. An allergist looks at whether your symptoms match your exposures before concluding that mold is the cause.

Are more people becoming allergic to mold?

The data can't answer that reliably. The two national surveys used different tests, which makes their results hard to compare. More recent data come from patients referred for testing, not a representative sample.

Which molds cause the most allergies?

In the 2023 US lab study, the most common fungal sensitizations were to Candida albicans, Alternaria alternata, and Stemphylium herbarum. Population surveys have focused on Alternaria, a common outdoor mold, and Aspergillus.

Where does the "3–10%" figure come from?

It appears in review articles, including a 2015 review that calls the exact prevalence of mold sensitization "not known." We couldn't trace the range to a specific US population study, so we don't use it as a headline number.

Sources

Keep exploring

More on mold & moisture.